search
Back to results

Emotional Freedom Technique in Early Pregnancy

Primary Purpose

Nausea Gravidarum, Anxiety, Emotion Regulation

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Emotional Freedom Technique
Sponsored by
Inonu University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Nausea Gravidarum focused on measuring Nausea, Vomiting, Anxiety, Emotional Freedom Technique, Pregnancy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Not having a verbal communication problem,
  • Being between the ages of 18-49,
  • 6-12th of pregnancy. be in the week
  • Not having a psychiatric disorder
  • Having a single, viable fetus
  • Absence of a fetal congenital malformation
  • Not having any disease other than pregnancy that will cause nausea and vomiting

Exclusion Criteria:

  • Diagnosing a risky pregnancy during the research process,
  • Asking to leave the research.

Sites / Locations

  • Inonu University Faculty of Health Sciences Pregnant Education Class

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental group

Control group

Arm Description

To the pregnant women in the experimental group; Emotional freedom technique was applied online with the researcher twice a week. PUQE, PRAQ-2 tests will be applied before the intervention, SUE and PUQE will be applied before and after each session, After 2 sessions, post-test data will be obtained with PUQE, SUE, PRAQ-2.

After each intervention applied to the experimental group, SUE and PUQE will be applied to the control group over the phone, simultaneously. After 1 week, post-test data will be obtained with PUQE, SUE, PRAQ-2.

Outcomes

Primary Outcome Measures

Subjective Units of Experience- (SUE)
The negative 10 feel the greatest pain, disappointment, fear, stress, sadness, or discomfort imaginable. When it reaches Positive 10, the client feels very different and wonderful. The meanings of the ratings in this range change gradually. The scale has no cutoff score. It is interpreted according to the mean of the scores and its relevance to other variables.

Secondary Outcome Measures

Descriptive Data
Pregnant information form prepared by the researcher in line with the literature, socio-demographic (pregnant woman's age, education and employment status, income status, family type and place of residence), obstetric (current gestational week and pregnancy history), psycho-social and medical history (desire for pregnancy) status, whether there is a chronic disease) consists of questions.
Pregnancy Unique Quantification of Emesis and Nausea- (PUQE)
The PUQE test questions the number of nausea attacks, the number of vomiting, and the number of retching. A tight agreement was observed between the results obtained from the PUQE test and the Rhodes test (30). In the evaluation of the Puqe test, the total score was 3-6 as mild, 7-12 as moderate, and 13-15 as severe nausea and vomiting.
Pregnancy-Related Anxiety Questionnaire-2 (PRAQ-2)
PRAQ-2 was developed by Van den Bergh in 1990 to measure the anxiety levels of women about their pregnancy periods and was revised by Huizink et al. It is a 5-point Likert-type scale, which was revised in 2016 to be applied to all pregnant women regardless of parity. It was adapted into Turkish by Aksoy Derya et al. The minimum and maximum scores that can be obtained from the scale are 11 and 55 for primiparas and 10 and 50 for multiparas, respectively. A score is calculated for each subscale of the PRAQ-2. As the score obtained from PRAQ-2 increases, the level of anxiety about pregnancy also increases. All statements in the questionnaire are positive statements. The scale does not have a breakpoint. The Cronbach's alpha reliability coefficient for the values calculated at various weeks of pregnancy was found to be between 0.71 and 0.85 in multiparas and between 0.75 and 0.84 in primiparas.

Full Information

First Posted
March 9, 2022
Last Updated
August 23, 2023
Sponsor
Inonu University
search

1. Study Identification

Unique Protocol Identification Number
NCT05337852
Brief Title
Emotional Freedom Technique in Early Pregnancy
Official Title
The Effect of Emotional Freedom Technique Applied in Early Pregnancy on Nausea, Vomiting and Anxiety
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
April 1, 2022 (Actual)
Primary Completion Date
June 30, 2022 (Actual)
Study Completion Date
June 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Inonu University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
One of the most common discomforts in early pregnancy is nausea and vomiting. Although its etiology is not known exactly, it affects an average of 50-90% of pregnant women. The severity of nausea-vomiting can vary from person to person, as well as in different pregnancies of the woman. The severity of nausea-vomiting is affected by hormonal, psychological and social factors. Adaptation to pregnancy, spouse relations, future anxiety and social support perception in nausea and vomiting experienced during early pregnancy affect women negatively and cause anxiety. The severity of nausea and vomiting also increases due to anxiety. As the severity of nausea-vomiting increases, the search for solutions to this situation and their applications to health institutions increase. Many non-pharmacological methods (respiratory exercises, acupuncture, acupressure, etc.) are used in treatment, as well as hydration, rest and pharmacological agents. One of these methods is the emotional liberation technique, which is included in cognitive behavioral therapies. This method basically treats the person physiologically and psychologically as a whole, similar to other cognitive behavioral therapies, unless there is a physiological disorder. It is aimed to reach a solution by raising awareness for the emotion felt, avoiding negative emotions and focusing on affirmations to replace them. Emotional liberation technique is an easy-to-apply and fast-solving technique in cases recorded in the subconscious with negative emotions and in the treatment of stress disorders in general. No use of emotional liberation technique has been found in the literature for the severity of nausea-vomiting and anxiety experienced during early pregnancy. Therefore, it is thought that this study will contribute to the literature. In addition, it is thought that this method will enrich midwifery interventions as a non-pharmacological method applied to pregnant women in the treatment of nausea-vomiting and anxiety, because this method is fast and practical, and the result is easy to reach. The aim of this study is to determine the effect of emotional liberation technique applied during early pregnancy on nausea and vomiting severity and anxiety.
Detailed Description
Pregnancy is a process that causes physiological, psychological and social changes in the female body. Pregnancy period consists of three different trimesters, divided into three-month periods. In each trimester, different physiological and psychological processes specific to pregnancy are experienced, and different approaches specific to these processes are required for the general well-being of the woman and the healthy progression of the pregnancy. Nausea-vomiting is one of the most common problems that occur during early pregnancy. Although its etiology is not known exactly, 50-90% of pregnant women are affected by this problem. It is thought that pregnancy hormones, gastrointestinal system disorders, hyperthyroidism, nutritional disorders and psychological factors cause nausea and vomiting or increase nausea-vomiting during early pregnancy. Nausea-vomiting in pregnancy; It is also called morning sickness, emesis gravidarum, pregnancy sickness. Nausea-vomiting during pregnancy starts on average in the 5th week of pregnancy, 8-12th week. It reaches its highest levels in the 16th weeks and is expected to decrease and disappear from the 16th week. It has been stated that the severity of nausea-vomiting during pregnancy varies from person to person, differs in each pregnancy of the person, and continues throughout the day, although it is often at the beginning of the day. Although many studies in this field focus on factors such as physiological, psychological, social and genetic, the common belief is that nausea and vomiting are based on psychological factors. Early pregnancy symptoms such as nausea and changes in the breasts pave the way for emotional changes. In emotional changes, women generally do not feel joy for the baby during this period, but they often experience opposite feelings by wanting their pregnancy to be known by everyone. Stress and emotional changes arising from these contrasts create anxiety processes. Anxiety is defined as a disorder characterized by fear, restlessness, restlessness, tension, and changes such as sweating, dyspnea, and sleep problems experienced for an unknown or unidentified reason. Anxiety disorders are more common in women than men, and anxiety disorders can be seen in 30% of women in their reproductive years. Studies have shown that the rate of anxiety disorders during pregnancy varies between 6% and 30%. Among the causes of anxiety in pregnancy; educational status, spousal relations, psycho-social support, family problems, presence of violence, and concerns about the baby. As a result of all these reasons, pregnancy hormones and neuroendocrine system are affected and cause nausea and vomiting. In addition, it is emphasized that unwanted pregnancy, perceived stress, acceptance of pregnancy are among the most important psychosocial factors that cause nausea and vomiting. Pregnant women with nausea-vomiting may have feelings of isolation, loneliness, guilt, may consider terminating their pregnancy, and may experience anxiety about the effect of nausea-vomiting on their baby. Pregnant women experience anxiety for reasons such as not being able to concentrate on their baby, worrying about the future, adapting to pregnancy and thinking only about their own health, and the need for intervention for these parameters is increasing. In psychoanalytic thought, nausea-vomiting during pregnancy is defined as a defense mechanism developed against unidentified discontent and the way the person expresses this situation. In order to change this discontent and the way of self-expression of the person, besides many psychotherapy methods, the emotional liberation technique, which is quick and easy to apply, and aims to reach the result in a short way by working on emotion-based, can have positive effects. Emotional liberation; It is an energy psychology technique that aims to free from negative emotions, clearing negative emotions, experiences, traumas and fears from the past and regulating the energy flow. Energy psychology, which has thousands of years of history in eastern cultures and has been used in the treatment of psychological problems in the West for the last 40 years, is not that human consists of independent parts; It is a new method based on the holistic approach, which is believed to have the knowledge of the whole of each part. According to energy psychology, it is in harmony with human physiology, mental processes, emotions and behaviors. Along with these processes, human is considered as a whole, including the environment and culture. It hypothesizes that psychological disorders and other health conditions are associated with disturbances in the body's electrical energies and these energy fields, as well as congestion or disruption. For this reason, emotional liberation technique, which is a non-pharmacological method, can be a practical method for psychological-based nausea-vomiting and anxiety by accepting the physiology, psychology, emotions and social environment of the pregnant as a whole.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nausea Gravidarum, Anxiety, Emotion Regulation, Vomiting of Pregnancy
Keywords
Nausea, Vomiting, Anxiety, Emotional Freedom Technique, Pregnancy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The randomized experiment was designed as a control study.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
110 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
To the pregnant women in the experimental group; Emotional freedom technique was applied online with the researcher twice a week. PUQE, PRAQ-2 tests will be applied before the intervention, SUE and PUQE will be applied before and after each session, After 2 sessions, post-test data will be obtained with PUQE, SUE, PRAQ-2.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
After each intervention applied to the experimental group, SUE and PUQE will be applied to the control group over the phone, simultaneously. After 1 week, post-test data will be obtained with PUQE, SUE, PRAQ-2.
Intervention Type
Other
Intervention Name(s)
Emotional Freedom Technique
Intervention Description
To the pregnant women in the experimental group; Emotional freedom technique was applied online with the researcher twice a week. The "release protocol of EFT" was taught to the participants and it was applied between the interviews made by the researcher. Whether the participant did the application or not was confirmed by phone and a homework schedule was used for smooth follow-up. PUQE, PRAQ-2 tests will be applied before the intervention, SUE and PUQE will be applied before and after each session, After 2 sessions, post-test data will be obtained with PUQE, SUE, PRAQ-2.
Primary Outcome Measure Information:
Title
Subjective Units of Experience- (SUE)
Description
The negative 10 feel the greatest pain, disappointment, fear, stress, sadness, or discomfort imaginable. When it reaches Positive 10, the client feels very different and wonderful. The meanings of the ratings in this range change gradually. The scale has no cutoff score. It is interpreted according to the mean of the scores and its relevance to other variables.
Time Frame
Each participant will be evaluated for 1 week.
Secondary Outcome Measure Information:
Title
Descriptive Data
Description
Pregnant information form prepared by the researcher in line with the literature, socio-demographic (pregnant woman's age, education and employment status, income status, family type and place of residence), obstetric (current gestational week and pregnancy history), psycho-social and medical history (desire for pregnancy) status, whether there is a chronic disease) consists of questions.
Time Frame
It will be obtained in 1 month at the beginning of the research.
Title
Pregnancy Unique Quantification of Emesis and Nausea- (PUQE)
Description
The PUQE test questions the number of nausea attacks, the number of vomiting, and the number of retching. A tight agreement was observed between the results obtained from the PUQE test and the Rhodes test (30). In the evaluation of the Puqe test, the total score was 3-6 as mild, 7-12 as moderate, and 13-15 as severe nausea and vomiting.
Time Frame
The time frame; pregnant women between 6 and 16 weeks included in the study will be evaluated for 4 weeks. It will take an average of 1 month to obtain the data. Measured PUQE scale data will be reported within 6 weeks at the end of the study.
Title
Pregnancy-Related Anxiety Questionnaire-2 (PRAQ-2)
Description
PRAQ-2 was developed by Van den Bergh in 1990 to measure the anxiety levels of women about their pregnancy periods and was revised by Huizink et al. It is a 5-point Likert-type scale, which was revised in 2016 to be applied to all pregnant women regardless of parity. It was adapted into Turkish by Aksoy Derya et al. The minimum and maximum scores that can be obtained from the scale are 11 and 55 for primiparas and 10 and 50 for multiparas, respectively. A score is calculated for each subscale of the PRAQ-2. As the score obtained from PRAQ-2 increases, the level of anxiety about pregnancy also increases. All statements in the questionnaire are positive statements. The scale does not have a breakpoint. The Cronbach's alpha reliability coefficient for the values calculated at various weeks of pregnancy was found to be between 0.71 and 0.85 in multiparas and between 0.75 and 0.84 in primiparas.
Time Frame
The time frame; pregnant women between 6 and 16 weeks included in the study will be evaluated for 4 weeks. It will take an average of 1 month to obtain the data. Measured PRAQ-R2 scale data will be reported within 6 weeks at the end of the study.

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Not having a verbal communication problem, 6-12th of pregnancy be in the week Not having a psychiatric disorder Having a single, viable fetus Absence of a fetal congenital malformation Not having any disease other than pregnancy that will cause nausea and vomiting Exclusion Criteria: Diagnosing a risky pregnancy during the research process, Asking to leave the research.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zeliha OZSAHİN
Organizational Affiliation
https://www.inonu.edu.tr/akademik/zeliha.ozsahin
Official's Role
Study Director
Facility Information:
Facility Name
Inonu University Faculty of Health Sciences Pregnant Education Class
City
Malatya
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Data will be obtained with Personal Information Form, Subjective Experience Units (SUE), Pregnancy Unique Quantification of Emesis (PUQE) and Pregnancy-Related Anxiety Questionnaire - R2 (PRAQ-R2).

Learn more about this trial

Emotional Freedom Technique in Early Pregnancy

We'll reach out to this number within 24 hrs